GTx, Inc. (GTXI)
$3.67
0.16 (+4.56%)
| CAPS Rating |
|
|---|---|
| Open | $3.50 |
| Previous Close | $3.51 |
| Daily Range | $3.50 - $3.78 |
| 52-Week Range | $3.22 - $18.75 |
| Market Cap | $133.66M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 931,272 |
| Average Daily Volume | 1,157,000 |
How do you think GTXI will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
GTXI Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
GTXI News and Commentary
- Seeking Alpha on GTX, Inc. – Ockham-RazorWire
- 3 Stocks Attracting Top Investors – The Motley Fool
- UPDATE 1-FDA denies approval for GTx drug;seeks additional study – Reuters
- Pharma's Next Home Run Drug Could Be 4 Singles Instead – The Motley Fool
- A Pfizer Drug With a Cloudy Future – The Motley Fool
- Whole Lotta Shorting Going On – The Motley Fool
- The Less-Flashy Prostate Cancer Treatment – The Motley Fool
Related News and Articles
- A Big Upgrade for Allos Therapeutics – The Motley Fool
- Now's a Great Time to Invest -- So Don't Blow It Like This – The Motley Fool
- This Stock Is a Train Wreck – The Motley Fool
- Drug Lowers Cholesterol; Stock Follows – The Motley Fool
- The Hottest Sector for 2010 – The Motley Fool
- Abbott: Brave or Stupid? – The Motley Fool
- 5-Star Stocks Poised to Pop: American Oriental Bioengineering – The Motley Fool
- Do You Have the Guts to Buy? – The Motley Fool
- This Top Stock Is a Winner – The Motley Fool
- Amylin Scores a Hat Trick – The Motley Fool
- 10 Stocks Shaking the Market – The Motley Fool


RSS Headlines
Fool UK